Denmark· DK-28106721321
Hyftor
A sirolimus product containing sirolimus, registered in Denmark by Plusultra Pharma GmbH. The same ATC class is registered in 6 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Sirolimus is registered in 6 of 19 countries.
Countries holding a registration under ATC L01EG04 (sirolimus), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 4 of them publish a price we can compare per daily dose
Sirolimus · ATC L01EG04
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Japan
- Norwayprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- SIROLIMUS
- Manufacturer
- Plusultra Pharma GmbH
- Country
- Denmark (DK)
- ATC code
- L01EG04
- ATC class
- Sirolimus
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106721321
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
737 interactions on record for sirolimus.
Graded by severity as the source publishes them — 162 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sirolimus · interactions on record
737 records
- 162 severe
- 441 moderate
- 8 minor
- 126 info
Most severe, free to view
- ClotrimazoleA01AB18severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01EG04
Sirolimus, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4f266170-fb59-49ab-a121-cf7205e81425 GET /v1/drugs/4f266170-fb59-49ab-a121-cf7205e81425?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "gel",
"source": "dkma",
"strength": "2 mg/g",
"auth_role": "MOD",
"dk_drugid": "28106721321",
"substance": "SIROLIMUS",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "45061"
}See everything about sirolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.